Adisorn Ratanaphan

Cellular responses of BRCA1-defective and triple-negative breast cancer cells and in vitro BRCA1 interactions induced by metallo-intercalator ruthenium(II) complexes containing chloro-substituted phenylazopyridine

Tidarat Nhukeaw, Pornvichai Temboot, K. Hansongnern et al. · BMC Cancer · 2014 · 37 citations · Full text

<i>In vitro</i> Ruthenation of Human Breast Cancer Suppressor Gene 1 (<i>BRCA1</i>) by the Antimetastasis Compound RAPTA‐C and Its Analogue CarboRAPTA‐C

Adisorn Ratanaphan, Pornvichai Temboot, Paul J. Dyson · Chemistry & Biodiversity · 2010 · 35 citations · Full text

Breast Oncology, Chemoprevention Strategy, Molecular Biology +21

The RING heterodimer BRCA1–BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs

Apichart Atipairin, Bhutorn Canyuk, Adisorn Ratanaphan · Breast Cancer Research and Treatment · 2010 · 33 citations

Tumor Biology, Platinum-based Anticancer Drugs, Medicine +11

Differential Cytotoxicity, Cellular Uptake, Apoptosis and Inhibition of BRCA1 Expression of BRCA1-Defective and Sporadic Breast Cancer Cells Induced by an Anticancer Ruthenium(II)-Arene Compound, RAPTA-EA1

Adisorn Ratanaphan, Tidarat Nhukeaw, Khwanjira Hongthong et al. · Anti-Cancer Agents in Medicinal Chemistry · 2017 · 31 citations · Full text

High-throughput genotyping by DHPLC of the dihydropyrimidine dehydrogenase gene implicated in (fluoro)pyrimidine catabolism

Katharina Seck, Steffi Neubauer, Jutta Mayr et al. · International Journal of Oncology · 2003 · 26 citations

Genetics, Genetic Epidemiology, Molecular Biology +21